Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,117 shares at $900.00 ($1.0M) on 2024-01-02, disclosed to the SEC on 2024-01-04.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |
| REGN | SELL | 2021-09-15 | $650K | — | Filing → |